Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the ...

Patents spanning 36 countries, including the United States, Europe, Canada, Australia, Japan, United Kingdom, India, Sweden, and Switzerland Additional 34 patents under review including 10 with the ...

The startup, which has already raised more than half a billion dollars, released Phase 2 results that could position its drug ...

Results from the Mariposa study found a regimen of Rybrevant and Lazcluze helped patients with a common form of advanced lung ...

In 2024, the company forged new partnerships with three of the largest, global pharmaceutical companies in the world, realizing a total of 10 partnerships with leading life science companies. Viz.ai ...

The three-year partnership is another example of Vertex’s interest in improving on Casgevy, its CRISPR medicine for sickle cell and beta thalassemia.